Praxis Precision Medicines
Tracked across 3 events · 20 articles · First seen Apr 02, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Praxis Precision Medicines announced that the United States — Food and Drug Administration accepted its New Drug Application for ulixacaltamide HCl, moving the company closer to commercial launch of a new therapy for essential tremor.
Apr 14, 2026 · 6 articles
Business
Impact: Praxis Precision Medicines, Inc. granted restricted stock unit awards to new non-executive employees under its 2024 Inducement Plan, which is a positive for the company's ability to attract and retain talent.
Apr 02, 2026 · 8 articles
Business
Impact: Dr. Daniel Baker provided critical guidance during the merger of Praxis Precision Medicines and Argus retinal prosthesis, which led to the formation of Vivani Medical.
Jun 26, 2026 · 6 articles
80
Praxis Precision Medicines granted awardsPraxis Precision Medicines...
ERGEN INTELLIGENCE
Track Praxis Precision Medicines live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard